about
Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allografts.Partial splenic embolization for hypersplenism after liver transplantation.Partial splenic embolization for hypersplenism before and after liver transplantation.Thigh grafts contribute significantly to patients' time on dialysis.A novel technique of portal-endocrine and gastric-exocrine drainage in pancreatic transplantation.Management of complications of simultaneous kidney-pancreas transplantation with temporary venting jejunostomy.Pancreatic transplantation: evaluation and management.Hepatocellular protection by nitric oxide or nitrite in ischemia and reperfusion injury.Management of giant liver cysts.Adrenal myelolipomas in patients with congenital adrenal hyperplasia: review of the literature and a case report.Surgical versus nonsurgical management of traumatic major pancreatic duct transection: institutional experience and review of the literature.Successful orthotopic liver transplantation after trimethoprim-sulfamethoxazole associated fulminant liver failure.Endoscopic diagnosis and management of biliary complications following orthotopic liver transplantation.Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients.Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients.The incidence and implications of renal cell carcinoma in cadaveric renal transplants at the time of organ recovery.Pancreatic transplantation and subsequent graft surveillance by pancreatic portal-enteric anastomosis and temporary venting jejunostomy.Metabolic alkalosis after orthotopic liver transplantation.Insulin prevents oxidant-induced endothelial cell barrier dysfunction via nitric oxide-dependent pathway.Timing of secondary arteriovenous fistula creation avoids tunneled catheter placement.End-stage renal disease in liver transplants.Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporineGraftula: A Composite Access Consisting of a Graft Used to Repair a Dysfunctional Hemodialysis FistulaLaparoscopic Versus Open Liver Resection for Benign and Malignant Solid Liver Tumors: A Case-Matched StudyRandomized Trial of Everolimus-Facilitated Calcineurin Inhibitor Minimization Over 24 Months in Renal TransplantationWound events in kidney transplant patients receiving de novo everolimus: a pooled analysis of three randomized controlled trialsA Penrose Drain to Help Reflect the Resected “Specimen Side” Jejunum Beneath the Mesenteric Vessels During a PancreaticoduodenectomyFlow PRA to detect clinically relevant HLA antibodiesEffects of Dextran and Pentoxifylline on Hemorrhagic Shock-Induced P-Selectin ExpressionThe Role of Ischemic Preconditioning in the Recruitment of Rolling and Adherent Leukocytes in Hepatic Venules after Ischemia/ReperfusionAnti-P-selectin antibody protects against hepatic ichemia–reperfusion injuryHepatic ischemia–reperfusion injury causes E-selectin upregulationICAM-1 upregulation in distant tissues after hepatic ischemia/reperfusion: A clue to the mechanism of multiple organ failureRole of P-selectin in the recruitment of leukocytes in mouse liver exposed to ischemia and reperfusionSmall-Bowel TumorsQuantification of P-selectin expression after renal ischemia and reperfusionSEROLOGIC ALLOGENEIC CHIMERISM
P50
Q30946797-BE513A73-F946-49C7-8A73-ECAF8ACCEBB0Q33340250-41079182-0248-4C1E-A130-D1FD6C490C9AQ33344622-1B7FA461-41B6-4DF1-96A7-E6238426391DQ33944848-0FCBF7B3-4B7E-4E52-B668-9C9C76344977Q34175688-D4303497-5DFD-4541-BE6D-C42C875FF134Q35149369-EF202FC6-04F2-4FE1-94B4-1F55D767F3D2Q35779083-5A71D064-0E7C-41C5-9B7B-B4E89F4C90B4Q37304773-DBD9AC0D-5725-4D03-AFDC-79AFA88D9990Q37680454-30FE4A73-044A-48BA-B006-04B20EB44A3CQ37842988-B3B16AC3-1957-4AC7-A448-01AA185A0275Q38023111-CB67036E-485D-461C-81B9-310A70D4CE6FQ40542803-39A9B921-3D7B-4F8F-84CC-AF8686953E6CQ41001114-6CA6868E-AD3C-4DC5-9716-665C6A77523CQ42640283-75CECBF9-4297-41DC-BA83-F97917A29DE9Q43067943-F46638C7-4B54-4B85-8ED9-A534E7AF1561Q43713046-A47096A0-F90F-4DB2-A3C6-3DE9A05912EFQ44603380-738BA99A-A133-4150-8CFC-1C91B644EE17Q44663040-5ADB4C08-1BB8-4779-ADA7-697E0B831823Q46859107-1989ABC1-9463-4CA4-8D89-1651FF726680Q47626402-84CEAEDC-F431-4663-9A1F-EB2FFEE9BC89Q54422675-A65599CE-84B5-4D21-868E-BF3A5203BC99Q57793005-1A576BC2-C11C-4813-958B-B4BA8A16F5EDQ57793013-479CDF51-AA3D-4B3B-A934-2D4D475A4696Q57793018-3B30441C-7A09-4197-B0F1-F9505E60DECDQ57793025-A89AFDD4-7641-4F1C-8846-03D7EA337C60Q57793035-83E003F4-6CE1-4B9D-A654-B80898D3A8D9Q57793050-D3965A78-B4A7-40CD-B271-9B64CF09E2ABQ57793183-54C66057-7553-4FF9-93E0-7B25E0D2D244Q57793222-6A2169C1-8AFD-4B78-8D08-F15D39E5C11CQ57793235-65CF1C95-1468-4FD1-BB8B-088D7CDBAB3FQ57793244-1CEA7779-4C9C-46F3-8689-26C01AE20640Q57793253-18D4DAB6-DC13-4622-AF16-680684CD75C3Q57793261-9E148996-AD04-4247-A131-00842959A32CQ57793269-EE338211-A3D7-48FE-B3B8-33CD10E7B8B3Q57793275-A7A4A945-209C-4506-854F-B95D9814476AQ57793294-E5E1E595-8E40-44F9-91C3-0D346CBB8EFDQ57793299-26AF61A0-8ED4-4FFD-B5B0-E16CD5D4B159
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gazi B. Zibari
@ast
Gazi B. Zibari
@en
Gazi B. Zibari
@es
Gazi B. Zibari
@nl
Gazi B. Zibari
@sl
type
label
Gazi B. Zibari
@ast
Gazi B. Zibari
@en
Gazi B. Zibari
@es
Gazi B. Zibari
@nl
Gazi B. Zibari
@sl
prefLabel
Gazi B. Zibari
@ast
Gazi B. Zibari
@en
Gazi B. Zibari
@es
Gazi B. Zibari
@nl
Gazi B. Zibari
@sl
P106
P1153
7005008957
P31
P496
0000-0001-7689-4299